1. Safety and tolerability of single intravenous doses of sugammadex administered simultaneously with rocuronium or vecuronium in healthy volunteers 
G Cammu, P.J. De Kam, I Demeyer, M Decoopman, P.A.M. Peeters, J.M.W. Smeets, L Foubert 
British Journal of Anaesthesia 
Volume 100, Issue 3, Pages (March 2008)
DOI: /bja/aem402
Copyright © 2008 British Journal of Anaesthesia Terms and Conditions

2. Fig 1
Semi log plots of plasma concentrations of sugammadex vs time after simultaneous administration with rocuronium 1.2 mg kg−1 (a) or vecuronium 0.1 mg kg−1 (b).
British Journal of Anaesthesia  , DOI: ( /bja/aem402)
Copyright © 2008 British Journal of Anaesthesia Terms and Conditions

3. Fig 2
Semi log plots of plasma concentrations of rocuronium 1.2 mg kg−1 (a) or vecuronium 0.1 mg kg−1 (b) vs time after simultaneous administration with sugammadex. NMBA, neuromuscular blocking agent.
British Journal of Anaesthesia  , DOI: ( /bja/aem402)
Copyright © 2008 British Journal of Anaesthesia Terms and Conditions

4. Fig 3
Molar ratios (ratio of concentrations in moles) of sugammadex/rocuronium (a) and sugammadex/vecuronium (b) vs time after simultaneous administration. NMBA, neuromuscular blocking agent.
British Journal of Anaesthesia  , DOI: ( /bja/aem402)
Copyright © 2008 British Journal of Anaesthesia Terms and Conditions